Modulating the Biology of ctDNA to Improve Liquid Biopsies

  • Liquid biopsies could improve cancer care but are constrained by insufficient ctDNA
  • Assay technologies can only partly overcome insufficient ctDNA
  • Methods to recover more ctDNA from the body could enable the next level of detection